Magazine Article | April 1, 2021

How Small Biotechs Can Implement Pharmacovigilance Systems

Source: Life Science Leader

By Steve Knowles

When it comes to implementing strong pharmacovigilance (PV) practices at your company, there is a variety of components and capabilities that will be necessary. Having worked in this space for most of my pharma industry career, I know it can be incredibly difficult to understand the intricacies of integrating these processes.

Pharmacovigilance is a catchall word used to describe anything that falls under the drug safety umbrella — detection, assessment, understanding, and prevention of adverse effects that may be associated with a medicine. It ensures that patients experience as little harm as possible when taking medications (clinically validated ones or otherwise).

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: